Evoke Pharma (EVOK) Interest & Investment Income (2020 - 2025)
Historic Interest & Investment Income for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to $107507.0.
- Evoke Pharma's Interest & Investment Income rose 827.14% to $107507.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $465854.0, marking a year-over-year increase of 8420.7%. This contributed to the annual value of $353313.0 for FY2024, which is 15492.29% up from last year.
- Latest data reveals that Evoke Pharma reported Interest & Investment Income of $107507.0 as of Q3 2025, which was up 827.14% from $112534.0 recorded in Q2 2025.
- In the past 5 years, Evoke Pharma's Interest & Investment Income ranged from a high of $126960.0 in Q4 2024 and a low of $795.0 during Q1 2022
- In the last 5 years, Evoke Pharma's Interest & Investment Income had a median value of $35331.0 in 2023 and averaged $47443.5.
- In the last 5 years, Evoke Pharma's Interest & Investment Income tumbled by 7487.36% in 2022 and then skyrocketed by 434415.09% in 2023.
- Over the past 5 years, Evoke Pharma's Interest & Investment Income (Quarter) stood at $1019.0 in 2021, then skyrocketed by 3098.04% to $32588.0 in 2022, then fell by 18.55% to $26544.0 in 2023, then soared by 378.3% to $126960.0 in 2024, then fell by 15.32% to $107507.0 in 2025.
- Its Interest & Investment Income stands at $107507.0 for Q3 2025, versus $112534.0 for Q2 2025 and $118853.0 for Q1 2025.